Taipei Veterans General Hospital, Taiwan
vghtpe.gov.twLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
328
Active
46
Phase 3
14
Total enrollment
215,261
Pipeline matrix
Showing 23 of 23 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Carvedilol | — | — | — | — | — | 1 | |
| Carvedilol alone | — | — | — | — | — | 1 | |
| Semaglutide 1.0 mg | — | — | — | — | — | 1 | |
| Semaglutide 0.5 mg | — | — | — | — | — | 1 | |
| Ertapenem | — | — | — | — | — | 1 | |
| Platelet-Rich Plasma | — | — | — | — | 2 | ||
| Pemetrexed | — | — | — | — | — | 1 | |
| HCB101 | — | — | — | — | — | 1 | |
| Pembrolizumab | — | — | — | — | — | 1 | |
| Taiwanese whole grain job's tear | — | — | — | — | — | 1 | |
| White job's tear | — | — | — | — | — | 1 | |
| Propofol | — | — | — | — | — | 3 | |
| Atorvastatin | — | — | — | — | 2 | ||
| Experimental: breast mask containing cabbage leaves extract group | — | — | — | — | — | 1 | |
| Sham Comparator | — | — | — | — | — | 1 | |
| Remimazolam | — | — | — | — | — | 1 | |
| Alglucosidase Alfa | — | — | — | — | — | 1 | |
| Chinese herbal tea TBDESJS | — | — | — | — | — | 1 | |
| Group that is receiving treatment. | — | — | — | — | — | 1 | |
| Nebulized 3% Hypertonic Saline | — | — | — | — | — | 1 | |
| Nebulized Normal Saline | — | — | — | — | — | 1 | |
| with U-VANCO | — | — | — | — | — | 1 | |
| without U-VANCO | — | — | — | — | — | 1 |
Next readouts
- 2023-12-31
- 2024-12
- 2025-04-30
- 2025-07-01
- 2025-12-19
- 2026-12
- 2026-12-31
- 2026-12-31
- 2027-09-12
- 2027-12-31
Top conditions
- Hepatocellular Carcinoma9
- Type 2 Diabetes7
- Stroke7
- Dry Eye Syndrome6
- Parkinson Disease6
- Anesthesia6
- Adhesive Capsulitis6
- Sjogren's Syndrome4
Frequently asked questions about Taipei Veterans General Hospital, Taiwan
- How many clinical trials does Taipei Veterans General Hospital, Taiwan have on ClinicalTrials.gov?
- Taipei Veterans General Hospital, Taiwan is listed as the lead sponsor on 328 clinical trials in ClinicalTrials.gov, 46 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Taipei Veterans General Hospital, Taiwan's trials are in Phase 3?
- 14 of Taipei Veterans General Hospital, Taiwan's trials are in Phase 3, spread across 23 active drug programs.
- What therapeutic areas does Taipei Veterans General Hospital, Taiwan focus on?
- Taipei Veterans General Hospital, Taiwan's most-studied conditions on ClinicalTrials.gov are Hepatocellular Carcinoma, Type 2 Diabetes, Stroke, Dry Eye Syndrome, Parkinson Disease.
- When are Taipei Veterans General Hospital, Taiwan's next clinical trial readouts?
- Taipei Veterans General Hospital, Taiwan has 10 upcoming primary-completion readouts tracked here; the soonest is “Higher Dose of Alglucosidase Alpha for Pompe Disease”, expected around 2023-12-31.